Try our Advanced Search for more refined results

Expert Analysis

Takeaways From Fed Circ. Opinions In Roche V. Apotex

Law360, New York (June 13, 2014, 12:42 PM EDT) -- In a recent Federal Circuit 2-1 decision in Hoffman-La Roche v. Apotex, (Fed. Cir. April 11, 2014), the majority held that Roche's discovery of a method of treating osteoporosis through the once-monthly, 150 mg oral administration of Boniva (ibandronate sodium, hereafter ibandronate) would have been obvious to one skilled in the relevant art, over the dissent of Judge Pauline Newman who would have held that the Boniva regimen success could not have been predicted and that important secondary considerations were not given proper weight....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Patents

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!